The Modern Age of Monoclonal Antibodies: The Revolution of Daratumumab
CD38 is a transmembrane glycoprotein expressed on the surface of different cell lines with several functions (receptor, adhesion molecule, ectoenzyme). Based on its high expression in multiple myeloma cells, CD38 is one of the main molecules used in the target therapy age. Daratumumab is the first f...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74833 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: The Modern Age of Monoclonal Antibodies: The Revolution of Daratumumab
- Monoclonal Antibodies for Cancer Treatment
- Biosimilar Monoclonal Antibodies in Latin America
- Application of Monoclonal Antibody Therapies in Autoimmune Diseases
- Monoclonal Antibody Therapy of T-Cell Leukemia and Lymphoma
- Introduction on Monoclonal Antibodies
- Quality Control by Immunoaffinity Concentration Using Monoclonal Antibody